Fabtech Technologies Ltd
Fabtech Technologies Q1 FY27: Revenue ₹9300 Cr
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #5 of 33 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Fabtech Technologies Ltd Q1 FY27 key numbers
- Revenue
- Active inquiries exceed ₹9300 crore with hot leads over ₹3800 crore, providing two-year sales visibility.
As stated in Fabtech Technologies Ltd's Q1 FY27 earnings call transcript · published 25 Aug 2026. Reported figures, not investment advice.
The short version
Fabtech Technologies aims for 20-25% year-on-year organic growth. Fabtech Technologies targets 20-25% year-on-year organic growth going forward (Page 9, 18, 21). - PAT guidance for current year is 9-11%, with aspirations toward 9.5-10% in the near term and 12% next year (Page 18). - Company aims for gradual margin expansion driven by a combination of gross margin improvement and operating leverage (Page 21). - Improvement in contribution margin was seen recently, expanding by ~900 basis points to 46.7% (Page 8). - Long-term vision includes reaching a 1000+ crore revenue mark by 2030 through organic growth (Page 18). - The business is seasonal with H2 typically stronger; growth in H2 is expected to be stronger than H1 (Page 9). - Company is working on contracts to shift revenue recognition more towards percentage completion method, which may improve profitability visibility (Page 20). - Profitability turnaround seen with net profit of Rs.
From Fabtech Technologies Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Fabtech Technologies aims for 20-25% year-on-year organic growth.
- Target to achieve ₹1000 crore+ top-line by 2030, considered a conservative estimate.
- Q2 is expected to be steady, with stronger H2 performance typically seen in the EPC design and build industry.
- Active inquiries exceed ₹9300 crore with hot leads over ₹3800 crore, providing two-year sales visibility.
- Growth driven by deeper localization, pipeline conversion with disciplined order selection focusing on quality, and integration of acquisitions to boost local execution.
- Expansion into GCC, Eastern and Southern Africa markets, notably through Fabtech Life Care in Saudi Arabia.
2 more points from Fabtech Technologies Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Fabtech Technologies Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Fabtech Technologies Limited has made strategic acquisitions to support growth:
- Acquired majority stake in Specialized Activities Contracting Establishment (SACE) in Saudi Arabia for local presence and bidding on HVAC MEP and civil projects.
- Ongoing due diligence for a European acquisition expected to drive future market entry, with completion anticipated within 2-3 quarters.
- Capital allocation focuses on execution, with working capital released only when order book growth and project requirements align.
- Acquisitions are strategically fit-driven, with capital deployment following due diligence and integration suitability.
2 more points from Fabtech Technologies Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Fabtech Technologies Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- The current open order book is reported to be over ₹900 crores (approximately ₹920+ crores considering exchange rate fluctuations).
- During Q1 FY27, new order inflows of ₹96.5 crores were added, while around ₹75 crores of orders were delivered.
- Order book revenue recognition does not occur evenly across quarters; Q1 is typically the lightest in revenue due to milestone-based recognition.
- Active inquiries exceed ₹9,300 crores in the total addressable funnel.
- Hot leads, representing advanced commercial or technical opportunities with a path to conversion, are valued over ₹3,800 crores.
2 more points from Fabtech Technologies Ltd's call on order book
Create a free account to keep reading this call
What the Q1 FY27 call signalled
4 of 4 strong
Fabtech Technologies Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹92 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Fabtech Technologies Ltd's management said in earlier quarters
Others in Healthcare Services this season
- Aatmaj Healthcare Ltd (Q1 FY27)
Revenue for Q1 FY 2026-27: ₹8.13 crore . Key investor presentation takeaways from Aatmaj Healthcare Ltd's Q1 FY27 investor presentation — and how it ranks again
- Asarfi Hospital Ltd (Q1 FY27)
Q1'FY27 consolidated revenue from operations: ₹47.5 Cr, up 32.8% YoY (vs ₹35.7 Cr in Q1'FY26) . Key investor presentation takeaways from Asarfi Hospital Ltd's Q
- KMC Speciality Hospitals (India) Ltd (Q1 FY27)
Q1 FY'27 Revenue from operations: INR 91.8 Cr, up 38% YoY from INR 66.6 Cr in Q1 FY'26. Key concall takeaways from KMC Speciality Hospitals (India) Ltd's Q1…
- 3B Blackbio DX Ltd (Q1 FY27)
Q1 2026-27 revenue from operations: ₹3,205.73 Lakh (including Coris sales of ₹862.83 Lakh) vs ₹1,996.06 Lakh in Q1 2025-26 — YoY growth approx. Key concall…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Fabtech Technologies Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Fabtech Technologies Ltd Q1 FY27 results?
Fabtech Technologies aims for 20-25% year-on-year organic growth. Fabtech Technologies targets 20-25% year-on-year organic growth going forward (Page 9, 18, 21). - PAT guidance for current year is 9-11%, with aspirations toward 9.5-10% in the near term and 12% next year (Page 18). - Company aims for gradual margin expansion driven by a combination of gross margin improvement and operating leverage (Page 21). - Improvement in contribution margin was seen recently, expanding by ~900 basis points to 46.7% (Page 8). - Long-term vision includes reaching a 1000+ crore revenue mark by 2030 through organic growth (Page 18). - The business is seasonal with H2 typically stronger; growth in H2 is expected to be stronger than H1 (Page 9). - Company is working on contracts to shift revenue recognition more towards percentage completion method, which may improve profitability visibility (Page 20). - Profitability turnaround seen with net profit of Rs.
What is Fabtech Technologies Ltd share price analysis?
Fabtech Technologies Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 13.8 with a market cap of ₹673 Cr. Investors should review the full earnings analysis for detailed insights.
Is Fabtech Technologies Ltd planning capital expenditure?
Fabtech Technologies Limited has made strategic acquisitions to support growth: - Acquired majority stake in Specialized Activities Contracting Establishment (SACE) in Saudi Arabia for local presence and bidding on HVAC MEP and civil projects.
Keep Fabtech Technologies Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.